Want to see IN:LAXMIDENTL full AI Analyst Report?
Laxmi Dental Ltd. (LAXMIDENTL) AI Stock Analysis
Laxmi Dental Ltd.
(NSE:LAXMIDENTL)
Financial performance weighs most on the score due to negative cash flows and margin pressure despite revenue gains and low debt. Bearish technicals add downside risk, while elevated valuation limits appeal.
Laxmi Dental Ltd. (LAXMIDENTL) vs. iShares MSCI India ETF (INDA)
- Market Cap
- INR 9.77B
- Dividend Yield
- ―
- Average Volume (3M)
- 6,249
- Price to Earnings (P/E)
- 31.4
- Beta (1Y)
- 1.35
- Revenue Growth
- ―
- EPS Growth
- ―
- Country
- India
- Employees
- 2,163
- Sector
- General
- Sector Strength
- 55
- Industry
- Medical - Instruments & Supplies
Laxmi Dental Ltd. Business Overview & Revenue Model
Company Description
Laxmi Dental Limited operates as a global manufacturer and supplier of diverse dental products, serving markets across India, the United States, the United Kingdom, and beyond. Its comprehensive portfolio includes personalized crowns, bridges, transp...
Laxmi Dental Ltd. Financial Statement Overview
Summary
Revenue growth of 17% and strong balance sheet with debt-to-equity at 0.05 are positives, but net margin drop to 10.4% and shift to negative operating cash flow of -50 million highlight cost and liquidity pressures.
Income Statement
60NeutralBalance Sheet
90Very PositiveCash Flow
35Negative| Breakdown | TTM | Mar 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.96B | 2.37B | 2.78B | 1.94B | 1.59B | 1.29B |
| Gross Profit | 1.14B | 734.47M | 776.94M | 1.49B | 345.70M | 220.26M |
| EBITDA | 386.04M | 522.20M | 434.00M | 254.15M | 108.27M | 63.84M |
| Net Income | 212.05M | 317.71M | 289.78M | 247.78M | -39.73M | -183.65M |
Balance Sheet | ||||||
| Total Assets | 2.66B | 2.86B | 2.94B | 1.35B | 965.38M | 1.03B |
| Cash, Cash Equivalents and Short-Term Investments | 246.19M | 1.09B | 1.04B | 9.73M | 15.80M | 14.33M |
| Total Debt | 89.07M | 195.12M | 130.09M | 497.77M | 387.11M | 386.82M |
| Total Liabilities | 369.58M | 774.87M | 498.60M | 899.51M | 770.56M | 798.04M |
| Stockholders Equity | 2.29B | 2.09B | 2.43B | 424.65M | 177.92M | 210.65M |
Cash Flow | ||||||
| Free Cash Flow | 93.81M | 277.54M | -233.68M | -66.06M | 44.58M | -116.06M |
| Operating Cash Flow | 224.02M | 438.32M | -49.97M | 81.51M | 144.41M | -19.95M |
| Investing Cash Flow | -951.76M | -292.42M | -795.84M | -108.05M | -93.94M | 30.42M |
| Financing Cash Flow | 952.94M | 1.11B | -177.52M | -26.63M | -14.51M | -40.27M |
Laxmi Dental Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:LAXMIDENTL, the sentiment is Negative. The current price of 177.75 is below the 20-day moving average (MA) of 186.11, below the 50-day MA of 192.43, and below the 200-day MA of 204.08, indicating a bearish trend. The MACD of -5.27 indicates Positive momentum. The RSI at 38.97 is Neutral, neither overbought nor oversold. The STOCH value of 47.47 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:LAXMIDENTL.
Laxmi Dental Ltd. Peers Comparison
Overall Rating
IN:GPTHEALTH60Neutral
IN:BOROSCI55Neutral
IN:POLYMED52Neutral- IN:LAXMIDENTL51Neutral
IN:THEMISMED45Neutral
IN:TARSONS44Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| IN:GPTHEALTH | 60Neutral | INR 10.89B | 23.03 | ― | 1.88% | 18.08% | -0.78% |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| IN:BOROSCI | 55Neutral | INR 9.09B | 20.98 | ― | ― | 12.07% | 289.29% |
| IN:POLYMED | 52Neutral | INR 146.76B | 46.62 | ― | 0.24% | 18.31% | -12.86% |
| IN:LAXMIDENTL | 51Neutral | INR 9.78B | 31.43 | ― | ― | ― | ― |
| IN:THEMISMED | 45Neutral | INR 8.75B | 21.85 | ― | 0.53% | -12.75% | ― |
| IN:TARSONS | 44Neutral | INR 15.52B | 139.23 | ― | ― | 10.63% | -59.63% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IN:LAXMIDENTL | Laxmi Dental Ltd. | 177.75 | -147.60 | -45.37% | |
| IN:BOROSCI | Borosil Scientific Limited | 102.15 | -33.95 | -24.94% | |
| IN:GPTHEALTH | GPT Healthcare Limited | 132.70 | -14.08 | -9.59% | |
| IN:POLYMED | Poly Medicure Limited | 1447.90 | -463.33 | -24.24% | |
| IN:TARSONS | Tarsons Products Limited | 291.75 | 2.70 | 0.93% | |
| IN:THEMISMED | Themis Medicare Limited | 95.00 | -29.64 | -23.78% |
Laxmi Dental Ltd. Corporate Events
Laxmi Dental Confirms IPO Proceeds Fully Aligned with Stated Objectives
Laxmi Dental Limited has released its monitoring agency report for the quarter ended September 30, 2026, confirming that the proceeds from its initial public offering have been utilized in line with the stated objects of the issue. The report, prepar...
Laxmi Dental secures exchange nod for ESOP share listing
Laxmi Dental Limited has obtained approvals from both the National Stock Exchange of India and BSE for the listing and trading of an additional 59,360 equity shares issued under its Laxmi Dental Employee Stock Option Scheme 2024. The new shares, carr...
Laxmi Dental clears Q1 FY27 results, ESOP allotment and Palghar land deal
Laxmi Dental Ltd. reported its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, following a board meeting held on August 11, 2026, in line with SEBI disclosure norms. The board also approved several corpora...
Laxmi Dental Publishes Q1 FY27 Investor Presentation on Unaudited Results
Laxmi Dental Limited has released an investor presentation tied to its Q1 FY27 earnings conference call, covering the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The presentation, made available in com...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 01, 2026